| Cas No.: | 1807523-99-4 |
| Chemical Name: | 5-(5-methyl-1-(3-(4-(methylsulfonyl)piperidin-1-yl)benzyl)-1H-1,2,4-triazol-3-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole hydrochloride |
| Synonyms: | IACS-010759 HCl; IACS-010759 hydrochloride; IACS-10759; IACS 10759; IACS10759; IACS-010759; IACS 010759; IACS010759. |
| SMILES: | LUSCFOVOISLXTM-UHFFFAOYSA-N |
| Formula: | C25H26ClF3N6O4S |
| M.Wt: | 599.0262 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | In Vitro IACS-10759 inhibits the conversion of NADH to NAD+ in an immunoprecipitated complex I assay at low nM concentrations. In Vivo IACS-10759 is orally bioavailable with excellent physicochemical properties in preclinical species and achieves significant in vivo efficacy with daily oral dosing of 10-25 mg/kg. There is a >50 day extension of median survival in an orthotopic AML cell line xenograft and robust regression in DLBCL and GBM xenograft models. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
